Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients.

Abstract

We evaluated in maintenance hemodialysis patients the potassium lowering effects of intravenous insulin with glucose, nebulized albuterol, and a regimen combining both modalities. There was a similar decrease in plasma potassium following either insulin with glucose (0.65 +/- 0.09 mmol/liter) or albuterol (0.66 +/- 0.12 mmol/liter), and a substantially… (More)

Topics

Cite this paper

@article{Allon1990AlbuterolAI, title={Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients.}, author={Michael A Allon and C Copkney}, journal={Kidney international}, year={1990}, volume={38 5}, pages={869-72} }